发明名称 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine receptor ligands
摘要 Disclosed are novel compounds of the formula: and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and cardiac reperfusion injury, acute pain, acute and chronic inflammatory pain, and neuropathic pain using a compound of formula IA.
申请公布号 US2004186142(A1) 申请公布日期 2004.09.23
申请号 US20030680393 申请日期 2003.10.07
申请人 SCHERING CORPORATION PHARMACOPEIA, INC. 发明人 TAVERAS ARTHUR G.;CHAO JIANHUA;BIJU PURAKKATTLE J.;YU YOUNONG;FINE JAY S.;HIPKIN WILLIAM;AKI CYNTHIA J.;MERRITT J. ROBERT;LI GE;BALDWIN JOHN J.;LAI GAIFA;WU MINGLANG;HECKER EVAN A.
分类号 A61K31/433;A61K31/4439;C07D285/10;C07D417/02;C07D417/12;C07D417/14;(IPC1-7):A61K31/443 主分类号 A61K31/433
代理机构 代理人
主权项
地址